The Epidemiology of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in the UK Noel Frey, Janine Jossi, Michael Bodmer, Andreas Bircher, Susan S. Jick, Christoph R. Meier, Julia Spoendlin Journal of Investigative Dermatology Volume 137, Issue 6, Pages 1240-1247 (June 2017) DOI: 10.1016/j.jid.2017.01.031 Copyright © 2017 The Authors Terms and Conditions
Figure 1 Comorbidities of SJS/TEN patients and control subjects in the CPRD. ∗Last cancer-related record < 1 year prior. †Last cancer-related record ≥ 1 year prior. CI, confidence interval; COPD, chronic obstructive pulmonary disease; CPRD, Clinical Practice Research Datalink; OR, odds ratio; SJS/TEN, Stevens-Johnson syndrome/toxic epidermal necrolysis; SSRI, selective serotonin reuptake inhibitor. Journal of Investigative Dermatology 2017 137, 1240-1247DOI: (10.1016/j.jid.2017.01.031) Copyright © 2017 The Authors Terms and Conditions